Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04314596
Other study ID # 1219
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 20, 2020
Est. completion date February 19, 2020

Study information

Verified date March 2020
Source Applied Science & Performance Institute
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Thirty active male and female athletes will be recruited for the study. Subjects will be examined at baseline for VO2max performance. Subjects will then be stratified and randomly divided equally (50% - 50%) into an Oceanix (supplemental) or placebo condition such that baseline VO2max match. Once randomization, subjects will be baseline tested for multiple measures of muscle force capacity, muscle soreness, immune function, and endocrine function. Upon completion of baseline testing, subjects will all complete a one-day, cross-training course in Tampa, Florida. The training course is known to be extremely vigorous and causes significant muscle damage. Subjects will then be retested for muscle function at 24, and 48 hours following the course. At 24- and 48-hours subjects will be asked to repeat a simulated time trial race. In this way, we will measure repeated race performance, recovery from intense exercise, muscle damage from exercise, and immune function during multiple races.


Recruitment information / eligibility

Status Completed
Enrollment 18
Est. completion date February 19, 2020
Est. primary completion date February 12, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- Males and females age 18 to 45 years old

- At least one year of cross training experience (i.e. 3 days/week)

Exclusion Criteria:

- BMI of 30 or more kg/m²

- Any allergies to fish, shellfish, algae, or seaweed are excluded from participation

- Have any cardiovascular, metabolic, or endocrine disease

- Undergone surgery that affects digestion and absorption

- Smoking

- Drink heavily (> 7 and > 14 drinks per week for women and men, respectively)

- Women who are pregnant or planning to be pregnant

- Taking medication to control blood pressure, lipids, and blood glucose

- Have taken or currently taking anabolic-androgenic steroids

Study Design


Intervention

Other:
Cross Training Course
One day of a supervised, whole body, cross-training course that is meant to produce muscle damage and soreness.
Dietary Supplement:
Oceanix
Ingredient contains highly active antioxidant enzymes, including superoxide dismutase (SOD), as well as essential fatty acids, vitamins, amino acids and minerals.

Locations

Country Name City State
United States Applied Science & Performance Institute Tampa Florida

Sponsors (2)

Lead Sponsor Collaborator
Applied Science & Performance Institute Lonza Ltd.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other VO2max Assessment of VO2max to determine fitness level and use as basis for randomization. Baseline
Primary Changes in muscle strength Assessed by isometric mid-thigh pull. Baseline, 24-Hour Post Cross-Training Course, 48-Hours Post Cross-Training Course.
Primary Changes in muscle power Assessed through ground reaction forces during countermovement and squat jumps on a force plate. Baseline, 24-Hour Post Cross-Training Course, 48-Hours Post Cross-Training Course.
Primary Changes in One(1) Mile Timed Run Experimental outcome assessing how quickly a 1 mile run can be completed. Baseline, 24-Hour Post Cross-Training Course, 48-Hours Post Cross-Training Course.
Primary Changes in Perceived Recovery Status (PRS) Assessed through a visual analog scale (modified Borg Scale) numbered 0 to 10 with visual descriptors. Baseline, 1 Day of Cross-Training Course, 24-Hour Post Cross-Training Course, 48-Hours Post Cross-Training Course.
Primary Changes in Rating of Perceived Exertion (RPE) Assessed through a visual analog scale numbered 0 to 10 with visual descriptors. Baseline, 1 Day of Cross-Training Course, 24-Hour Post Cross-Training Course, 48-Hours Post Cross-Training Course.
Primary Changes in Perceived Soreness Scale Assessed through a visual analog scale numbered 0 to 10 with visual descriptors. Baseline, 1 Day of Cross-Training Course, 24-Hour Post Cross-Training Course, 48-Hours Post Cross-Training Course.
Secondary Creatine Kinase Experimental outcome examining creatine kinase in fasted whole blood samples. This is biomarker an indirect measure of muscle damage. Baseline, 24-Hour Post Cross-Training Course, 48-Hours Post Cross-Training Course.
Secondary Cortisol Experimental outcome examining the concentration of cortisol in fasted saliva samples. Baseline, 24-Hour Post Cross-Training Course, 48-Hours Post Cross-Training Course.
See also
  Status Clinical Trial Phase
Completed NCT03255187 - Effect of Dietary Supplemental Fish Oil in Alleviating Health Hazards Associated With Air Pollution N/A
Completed NCT04136821 - The Long-term Effects of Oceanix™ on Resistance Training Adaptations N/A
Recruiting NCT03790345 - Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics Phase 2/Phase 3
Completed NCT03358524 - Effects of Vitamin E Supplementation on Free Radicals and Fat Level of Obese Adolescence in Jakarta, Indonesia Phase 4
Recruiting NCT05327348 - Effectiveness of IV Vitamin C in Reducing Oxidative Stress Associated With Free Flap Surgery Phase 3
Completed NCT03288623 - The Effects of Dark Chocolate Implementation in Elite Athletes N/A
Completed NCT04419025 - Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease Phase 2
Completed NCT04597983 - Effect of 8-week Intake of 2S-hesperidin on Performance, Body Composition and Biochemicals Markers in Amateur Cyclists N/A
Not yet recruiting NCT06159543 - The Effects of Fresh Mango Consumption on Cardiometabolic Outcomes in Free-living Individuals With Prediabetes N/A
Enrolling by invitation NCT03030456 - Whole Body Vibrations on Functional Capacity, Muscular Strength, and Biochemical Profile in Elders N/A
Completed NCT02256254 - SIMOX - Induction of Oxidative Stress Phase 2
Not yet recruiting NCT02202239 - Effect of Induction and Maintenance of Anesthesia With Etomidate on Hemodynamics and Oxidative Stress in Diabetic Patients Phase 4
Recruiting NCT02048592 - Impact of Immunonutrition on the Patients With Cystic Fibrosis Phase 4
Completed NCT01942460 - Ferumoxytol for Iron-Deficiency Anemia in Chronic Kidney Disease and Peritoneal Dialysis Patients Phase 4
Completed NCT02463318 - The Effect of Melatonin on Gene Expression and Activity of the Sirt1 and Its Target Genes Catalase and MnSOD in Multiple Sclerosis Patients and Healthy Subjects N/A
Completed NCT02177383 - Action of Essential Fatty Acids on the Expression of Antioxidant Genes and Athletic Performance N/A
Completed NCT01990391 - Brazil Nut Consumption in Microvascular Endothelial Function, Oxidative Stress and Metabolic Abnormalities N/A
Completed NCT00845130 - Quantitative in Vivo Biomarkers of Oxidative Stress in Diabetes N/A
Completed NCT00607893 - Efficacy of Continuous Positive Airway Pressure in Reducing Oxidative Stress in Individuals With Sleep Apnea N/A
Active, not recruiting NCT00247507 - The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients Phase 4